Bank of Montreal’s Loxo Oncology, Inc LOXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-11,770
Closed -$1.65M 5060
2018
Q4
$1.65M Buy
11,770
+416
+4% +$63.1K ﹤0.01% 1631
2018
Q3
$1.94M Buy
11,354
+3,198
+39% +$537K ﹤0.01% 1685
2018
Q2
$1.42M Buy
8,156
+7,298
+851% +$1.1M ﹤0.01% 1817
2018
Q1
$99K Buy
858
+400
+87% +$42.5K ﹤0.01% 2971
2017
Q4
$39K Buy
+458
New +$38.2K ﹤0.01% 3364
2016
Q4
Sell
-71
Closed -$2K 4277
2016
Q3
$2K Hold
71
﹤0.01% 3887
2016
Q2
$2K Sell
71
-110
-61% -$2.74K ﹤0.01% 3929
2016
Q1
$5K Buy
181
+110
+155% +$2.3K ﹤0.01% 3816
2015
Q4
$2K Buy
+71
New +$1.91K ﹤0.01% 4020

Other funds holding LOXO

Bank of Montreal's LOXO Position: Q1 2019 in Review

Bank of Montreal sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 11,770 shares — an estimated $1.65M sold.

Bank of Montreal first reported a position in LOXO in Q4 2015 and held it in 9 quarters. The position peaked at $1.94M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Bank of Montreal reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Bank of Montreal sold 11,770 Loxo Oncology, Inc shares in Q1 2019, an estimated $1.65M.
  • Bank of Montreal first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 9 quarters.
  • Bank of Montreal's Loxo Oncology, Inc position peaked at $1.94M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.